Clinical Trials Browser

Multiple Myeloma, Recurrence

Multiple Myeloma, Recurrence

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

Chromosome 17 deletion, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Multiple Myeloma, Recurrence

Multiple Myeloma, Recurrence

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Marginal Zone

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence

Recurrence, Endometrial Neoplasms

Lymphoma, Follicular, Recurrence

Prostatic Neoplasms, Recurrence

Burkitt Lymphoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Lymphoma, Follicular, Recurrence

Neoplasm Metastasis, Recurrence

Multiple Myeloma, Recurrence

Multiple Myeloma, Recurrence

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

Disease, Recurrence, Leukemia, Myeloid, Acute

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Lymphoma, T-Cell, Peripheral

Multiple Myeloma, Recurrence

Carcinoma, Renal Cell, Kidney Neoplasms, Recurrence

Urinary Bladder Neoplasms, Recurrence

Lymphoma, Follicular, Recurrence

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence

Clinical Trials

SUCCESSOR-1

A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

FourLight-3

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

OLYMPIA-5

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

RAINFOL-03

Celestimo

MEVPRO-1

Study of Out of Specification for Tisagenlecleucel

LEDA

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

MonumenTAL-3

MajesTEC-9

FIERCE-HN

IMPACT-AML

TERZO

SUCCESSOR-2

LUTEON

EVER

A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma

AB02